Jacob Scott, Professor and Co-Director, Center for Enabling Discovery in Disease Biology (AID2B) at the Case Western Reserve University School of Medicine, shared a post on X about a recent article he and colleagues authored:
“In time for ASTRO25 – studying the effect of genomics in radiation outcomes for HPV+ oropharyngeal cancer.
Trying to answer the tricky dose de-escalation question and a new population-based paradigm for outcome optimization.
Thanks, National Cancer Institute 4 funding.”
Title: Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation dose
Authors: Emily Ho, Loris De Cecco, Steven A. Eschrich, Stefano Cavalieri, Geoffrey Sedor, Frank J. Hoebers, Ruud H. Brakenhoff, Kathrin Scheckenbach, Tito Poli, Kailin Yang, Jessica A. Scarborough, Shivani Nellore, Shauna R. Campbell, Neil M. Woody, Timothy A. Chan, Jacob Miller, Natalie L. Silver, Shlomo Koyfman, James E. Bates, Jimmy J. Caudell, Michael W. Kattan, Lisa Licitra, Javier F. Torres-Roca, Jacob G. Scott
Read the Full Article in the Journal of Clinical Investigation.
More posts featuring ASTRO25 on OncoDaily.